Clinical Trial Update: Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating 3D185 as monotherapy in adults with previously treated locally advanced or metastatic cholangiocarcinoma; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• 3D185

Snippet

Sponsor: 3D Medicines (Beijing) Co., Ltd. | Conditions: Cholangiocarcinoma,Adult | Phase 2 | Status: NOT_YET_RECRUITING